acute lymphoblastic leukemia | 2 Minute Medicine

Originally published by Harvard Health. What Is It? Acute lymphocytic leukemia (ALL) is a type of leukemia. Leukemia is a ...

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Phase II trial reports leukemia remissions using engineered T cell therapy

byTomi Junand1 others

October 15, 2014

0

1. 90% of relapsed B-cell acute lymphoblastic leukemia (ALL) patients achieved complete remission 1 month after an infusion of engineered ...

Combo angiotensin-neprilysin inhibitor superior to enalapril in heart failure [PARADIGM-HF trial]

2 Minute Medicine Rewind September 8 – September 14, 2014

byNeal Yuanand1 others

September 15, 2014

0

In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Angiotensin–Neprilysin ...

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

byMatthew Growdonand1 others

September 11, 2014

0

1. The prevalence of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) increased with age and was associated with worse overall ...